Skip to main content
Livermore
Livermore
ZHEN

Amalgamated Bank

SEC CIK
0000919192
Latest filing
Jul 23, 2026

AXSM holding history

Axsome Therapeutics, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AXSM overviewAll 13F holders of AXSMFull Q2 2026 holdings

Shares (Q2 2026)
3,127
Value
$765.0K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of AXSM by Amalgamated Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,127$765.0K<0.1%+1,838+142.6%AddedHolders
Q1 20261,289$218.0K<0.1%00.0%UnchangedHolders
Q4 20251,289$235.0K<0.1%+20+1.6%AddedHolders
Q3 20251,269$154.0K<0.1%00.0%UnchangedHolders
Q2 20251,269$132.0K<0.1%00.0%UnchangedHolders
Q1 20251,269$148.0K<0.1%+17+1.4%AddedHolders
Q4 20241,252$106.0K<0.1%00.0%UnchangedHolders
Q3 20241,252$113.0K<0.1%00.0%UnchangedHolders
Q2 20241,252$101.0K<0.1%+36+3.0%AddedHolders
Q1 20241,216$97.0K<0.1%−3,874−76.1%ReducedHolders
Q4 20235,090$405.0K<0.1%−139−2.7%ReducedHolders
Q3 20235,229$365.0K<0.1%+257+5.2%AddedHolders
Q2 20234,972$357.0K<0.1%+443+9.8%AddedHolders
Q1 20234,529$279.0K<0.1%−750−14.2%ReducedHolders
Q4 20225,279$407.0K<0.1%+467+9.7%AddedHolders
Q3 20224,812$215.0K<0.1%+261+5.7%AddedHolders
Q2 20224,551$174.0K<0.1%+26+0.6%AddedHolders
Q1 20224,525$187.0K<0.1%+4,525NewHolders
Q3 20210$00.0%−5,248−100.0%Sold outHolders
Q2 20215,248$354.0K<0.1%+1,308+33.2%AddedHolders
Q1 20213,940$223.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.